Company Lepu Medical Technology (Beijing) Co., Ltd.
Equities
300003
CNE100000H44
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13.89 CNY | -1.00% |
|
+3.66% | -14.05% |
Business Summary
- sale of medical devices and instruments (57.9%): primarily for cardiovascular interventions, cardiac surgery, cardiac rhythm management, anesthesia, intensive care, in vitro diagnostics and general surgery;
- sale of active pharmaceutical ingredients (30.6%): for the manufacturing of pharmaceutical products in the fields of cardiovascular diseases, infectious diseases, oncology, central nervous system disorders, etc.;
- sale of digital health and hospital network management solutions (11.6%).
China accounts for 64.7% of net sales.
Sales per Business
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Medical Equipment
46.0
%
| 5,879 | 55.4 % | 3,674 | 46.0 % | -37.50% |
Pharmaceutical
38.1
%
| 3,438 | 32.4 % | 3,044 | 38.1 % | -11.47% |
Medical Services and Health Management
15.8
%
| 1,293 | 12.2 % | 1,262 | 15.8 % | -2.37% |
Sales per region
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
100.0
%
| 9,529 | 89.8 % | 7,980 | 100.0 % | -16.25% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Zhi Bin Zhang
CEO | Chief Executive Officer | 48 | 21-04-25 |
Wang Yong
DFI | Director of Finance/CFO | 51 | 07-02-28 |
Zhong Jie Pu
CHM | Chairman | 61 | - |
Jing Jing Li
IRC | Investor Relations Contact | - | - |
Guo Rui Zheng
PRN | Corporate Officer/Principal | 41 | 21-03-31 |
Xiao Yong Wang
SAM | Sales & Marketing | 47 | 16-12-31 |
Wei Na Jiang
SEC | Corporate Secretary | 45 | 21-07-13 |
Zhan Jiang Wei
PRN | Corporate Officer/Principal | 52 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Zhong Jie Pu
CHM | Chairman | 61 | - |
Yang Xu
BRD | Director/Board Member | 57 | 13-12-31 |
Liang Gan
BRD | Director/Board Member | 57 | 20-01-21 |
Qian Chen
BRD | Director/Board Member | 46 | 13-12-26 |
Li Hua Wang
BRD | Director/Board Member | 62 | 20-04-20 |
Fei Pu
BRD | Director/Board Member | 35 | 20-01-21 |
Xing Lin Wang
CHM | Chairman | 62 | 20-01-21 |
Jun Wang
BRD | Director/Board Member | 49 | 20-01-21 |
Qi Hong Wang
BRD | Director/Board Member | 59 | 21-03-24 |
Xin Qu
BRD | Director/Board Member | 61 | 21-03-09 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,915,405,539 | 1,178,795,151 ( 61.54 %) | 34,794,981 ( 1.817 %) | 61.54 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
280,000,000 | 80.75% | 687,859,200 $ | |
LEPU BIOPHARMA CO., LTD. 13.61% | 225,352,113 | 13.61% | 102,179,155 $ |
18,273,500 | 1.13% | 37,321,431 $ | |
BIOLINERX LTD. 8.54% | 102,437,055 | 8.54% | 4,169,188 $ |
Company contact information
Lepu Medical Technology (Beijing) Co., Ltd.
No. 37 Chaoqian Road Changping District
102200, Beijing
+86 10 8012 0666
http://www.lepumedical.com![address Lepu Medical Technology (Beijing) Co., Ltd.(300003)](https://cdn.zonebourse.com/static/address/6500424.png)
Sector
Sales per Business
Sales per region
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.05% | 3.6B | |
-6.46% | 181B | |
-6.43% | 99.95B | |
-7.28% | 66.21B | |
+16.45% | 45.4B | |
-8.93% | 45.36B | |
+8.19% | 43.84B | |
+12.00% | 29.03B | |
+17.98% | 25.64B | |
-9.09% | 23.53B |
- Stock Market
- Equities
- 300003 Stock
- Company Lepu Medical Technology (Beijing) Co., Ltd.